HAP Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $840K | Buy |
23,900
+13,600
| +132% | +$2.77M | 0.06% | 201 |
|
|
2025
Q2 | $124K | Sell |
10,300
-300
| -3% | -$55.8K | 0.01% | 399 |
|
|
2025
Q1 | $241K | Sell |
10,600
-4,100
| -28% | -$797K | 0.03% | 285 |
|
|
2024
Q4 | $45.9K | Buy |
+14,700
| New | +$2.7M | ﹤0.01% | 477 |
|
|
2024
Q3 | – | Sell |
-86,300
| Closed | -$242K | – | 674 |
|
|
2024
Q2 | $242K | Buy |
+86,300
| New | +$14.3M | 0.03% | 261 |
|
|
2024
Q1 | – | Sell |
-13,400
| Closed | -$65.1K | – | 689 |
|
|
2023
Q4 | $65.1K | Sell |
13,400
-1,000
| -7% | -$146K | 0.01% | 416 |
|
|
2023
Q3 | $34K | Sell |
14,400
-15,400
| -52% | -$2.26M | 0.01% | 585 |
|
|
2023
Q2 | $9.24K | Buy |
29,800
+11,200
| +60% | +$1.64M | ﹤0.01% | 836 |
|
|
2023
Q1 | $105K | Sell |
18,600
-13,400
| -42% | -$2.05M | 0.02% | 387 |
|
|
2022
Q4 | $578K | Buy |
32,000
+1,800
| +6% | +$276K | 0.06% | 271 |
|
|
2022
Q3 | $240K | Sell |
30,200
-92,000
| -75% | -$13.2M | 0.02% | 548 |
|
|
2022
Q2 | $983K | Buy |
122,200
+72,700
| +147% | +$11.1M | 0.05% | 294 |
|
|
2022
Q1 | $1.17M | Sell |
49,500
-48,288
| -49% | -$7.01M | 0.05% | 307 |
|
|
2021
Q4 | $1.27M | Sell |
97,788
-273,100
| -74% | -$32.3M | 0.03% | 409 |
|
|
2021
Q3 | $236K | Buy |
370,888
+328,328
| +771% | +$37.5M | 0.01% | 967 |
|
|
2021
Q2 | $231K | Buy |
42,560
+14,500
| +52% | +$1.63M | 0.01% | 950 |
|
|
2021
Q1 | $126K | Sell |
28,060
-42,430
| -60% | -$4.54M | 0.01% | 879 |
|
|
2020
Q4 | $696K | Sell |
70,490
-3,686
| -5% | -$354K | 0.02% | 518 |
|
|
2020
Q3 | $234K | Sell |
74,176
-12,440
| -14% | -$1.17M | 0.01% | 590 |
|
|
2020
Q2 | $913K | Sell |
86,616
-25,184
| -23% | -$2.22M | 0.05% | 288 |
|
|
2020
Q1 | $214K | Buy |
111,800
+22,900
| +26% | +$1.95M | 0.01% | 529 |
|
|
2019
Q4 | $231K | Buy |
88,900
+49,000
| +123% | +$4.07M | 0.01% | 433 |
|
|
2019
Q3 | $208K | Buy |
39,900
+6,800
| +21% | +$466K | 0.02% | 480 |
|
|
2019
Q2 | $47K | Buy |
33,100
+11,500
| +53% | +$904K | ﹤0.01% | 745 |
|
|
2019
Q1 | $25K | Buy |
21,600
+7,500
| +53% | +$614K | ﹤0.01% | 786 |
|
|
2018
Q4 | $48K | Buy |
14,100
+200
| +1% | +$17.6K | ﹤0.01% | 755 |
|
|
2018
Q3 | $40K | Sell |
13,900
-39,300
| -74% | -$3.73M | ﹤0.01% | 656 |
|
|
2018
Q2 | $39K | Sell |
53,200
-48,900
| -48% | -$4.78M | ﹤0.01% | 718 |
|
|
2018
Q1 | $111K | Sell |
102,100
-355,000
| -78% | -$39M | 0.01% | 534 |
|
|
2017
Q4 | $112K | Buy |
457,100
+333,800
| +271% | +$31.5M | ﹤0.01% | 566 |
|
|
2017
Q3 | $701K | Buy |
123,300
+104,100
| +542% | +$7.92M | 0.03% | 310 |
|
|
2017
Q2 | $77K | Sell |
19,200
-10,400
| -35% | -$699K | ﹤0.01% | 628 |
|
|
2017
Q1 | $35K | Buy |
29,600
+5,200
| +21% | +$327K | ﹤0.01% | 739 |
|
|
2016
Q4 | $26K | Sell |
24,400
-14,200
| -37% | -$867K | ﹤0.01% | 738 |
|
|
2016
Q3 | $21K | Sell |
38,600
-13,100
| -25% | -$848K | ﹤0.01% | 852 |
|
|
2016
Q2 | $65K | Buy |
51,700
+40,100
| +346% | +$2.44M | ﹤0.01% | 567 |
|
|
2016
Q1 | $16K | Sell |
11,600
-147,100
| -93% | -$8.2M | ﹤0.01% | 639 |
|
|
2015
Q4 | $118K | Buy |
158,700
+24,300
| +18% | +$1.4M | 0.01% | 541 |
|
|
2015
Q3 | $49K | Buy |
134,400
+82,684
| +160% | +$5.38M | ﹤0.01% | 698 |
|
|
2015
Q2 | $170K | Buy |
51,716
+13,216
| +34% | +$863K | 0.01% | 498 |
|
|
2015
Q1 | $37K | Sell |
38,500
-400,900
| -91% | -$24.2M | ﹤0.01% | 654 |
|
|
2014
Q4 | $4.65M | Buy |
+439,400
| New | +$27.7M | 0.17% | 123 |
|
|
2014
Q2 | – | Sell |
-21,000
| Closed | -$10K | – | 919 |
|
|
2014
Q1 | $10K | Buy |
21,000
+11,000
| +110% | +$556K | ﹤0.01% | 910 |
|
|
2013
Q4 | $29K | Buy |
+10,000
| New | +$491K | ﹤0.01% | 938 |
|
Other funds holding ABBV
HAP Trading's ABBV Position: Q3 2025 in Review
HAP Trading sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 14,777 shares — an estimated $3.01M sold.
HAP Trading first reported a position in ABBV in Q2 2013 and held it in 24 quarters. The position peaked at $17.2M in Q2 2013. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- HAP Trading reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 14,777 AbbVie shares in Q3 2025, an estimated $3.01M.
- HAP Trading first reported a position in AbbVie in Q2 2013 and held it in 24 quarters.
- HAP Trading's AbbVie position peaked at $17.2M in Q2 2013.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.